Philips establishes European telemedicine joint venture

Article

Royal Philips Electronics has taken an 80% stake in a joint venture with SHL TeleMedicine to develop new markets for cardiology telemedicine products and services across Europe. The goal is to establish medical call centers and remote

Royal Philips Electronics has taken an 80% stake in a joint venture with SHL TeleMedicine to develop new markets for cardiology telemedicine products and services across Europe. The goal is to establish medical call centers and remote monitoring services for people with cardiac disease. The venture is headquartered in the Netherlands and managed by a joint Philips/SHL team. SHL, an Israeli provider of personal telemedicine systems and call center services, has the option of increasing its stake to 35% in the future. The company claims more than 55,000 subscribers to its services in Israel and already oversees operations in the U.K., Portugal, and Croatia through similar joint-venture arrangements with other partners.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.